Companies
The latest research, products, and discoveries from the science industry’s leading companies and company divisions.
NanoCellect is committed to empowering every scientist to make discoveries one cell at a time, with modern and simple technologies for cell based assays. Our microfluidic flow cytometry platforms enable biomedical scientists to analyze and sort cells required for drug discovery, diagnostics, and basic research. The company was founded in late 2009 as a spinout from UCSD and dedicated 6 years developing the foundation of the WOLF's technology before introducing the WOLF to early adopters. Initial funding of R&D was graciously funded by multiple NIH SBIR grants and contracts. We are backed by Illumina Ventures, FusionX Ventures, Anzu Partners, Agilent Technologies, Vertical Ventures (Highlander Fund and Triton Fund) and other private investors.
NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications. NanoString's products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection, and in 2013 launched Prosigna®, its first in vitro diagnostic product for prognosis of early stage breast cancer. Organizations performing cancer research, biomarker validation and screening, and next-generation sequencing validation are rapidly adopting the nCounter® Analysis System. By providing simple, multiplexed digital profiling of single molecules, the NanoString platform represents a natural, digital downstream companion to next-generation sequencing and enables researchers to embark on studies that were previously inconceivable. Leading researchers and institutions are finding that NanoString's nCounter system provides the ideal platform on which to validate their discoveries and translate them into clinically useful diagnostic assays. The nCounter system is uniquely positioned to support translational research because it provides more reproducible results than methods requiring amplification, and generates high-quality data from the difficult sample types common in clinical research, including Formalin-Fixed Paraffin-Embedded (FFPE) tissues. In addition to continuing to extend the applications for the nCounter system in the discovery, target validation and routine testing segments of the genomics research market, the company's goal is to become the platform of choice for diagnostic testing based on multiplexed gene signatures that can be offered in hospitals and pathology laboratories worldwide, following appropriate regulatory approvals. These two synergistic areas of business focus provide researchers with a seamless transition from discovery to diagnostics.
NanoTemper Technologies is deeply committed to the best customer experience. Central to this is a strong focus on enabling researchers to easily, efficiently, and accurately perform protein characterization. With a broad offering of systems, software and consumables for evaluating binding affinities and protein stability, scientists in pharmaceutical, biotech or academic labs will find an optimized workflow, quality results and responsive customer support. Work with a deeply experienced and globally operating team, and realize the NanoTemper experience.
Natera® is a rapidly growing genetic testing and diagnostics company with proprietary bioinformatics and molecular technology. Natera's team of PhDs and engineers is dedicated to refining novel molecular genome assays and complex statistical algorithms to determine the likelihood of a wide range of serious genetic conditions with best-in-class accuracy and coverage. Natera's goal is to change the management of genetic disease worldwide, giving patients and providers essential health information.
Navitar designs, develops and manufactures innovative optical solutions for clients and enterprises across the globe. Solutions include complete optomechanical and optoelectronic assembly and sub-assembly systems. Our products range from high magnification motorized zoom imaging systems to fisheye projection lenses used in a wide variety of industries including Life Sciences, Industrial Imaging, Microscopy and Projection.
The key to our success is our consultative approach to solving complex optical problems through inventive design techniques, the precision at which product is assembled, and the efficiency in which projects move through our business units.
Neutec Group provides cost effective Instrument and Automation Solutions which enhance the productivity of the Micro and Biotech Labs. Our products are distinguished by innovative design, durability, reliability, and value - the same qualities we look for when selecting partners. We integrate the products we represent with accessories, interface them with computers and printers, and build complete laboratory solutions to meet your specific needs. Some of our products include: Agar & Tube Fillers, Media Preparators, our innovative Spiral Plater, Automatic Colony Counters, Petri Labeler, Water Activity Meters, Multi Spectral imaging texture/color analyzer.
On behalf of the Board of Directors and members, I thank you in advance for your interest in the New Jersey Association for Biomedical Research (NJABR). As one of the best advocacy organizations representing the biomedical research community in the country, we look forward to the opportunity to partner with you and work to advance human and animal health together. Members utilize our services and benefits in many different ways, but NJABR is known for the development of internationally recognized educational programming and legal and legislative monitoring. NJABR is not afraid to address the controversial issues that impact the research community and we advocate tirelessly to increase the understanding of the critical role and value of animal research. We advocate for continued access to all biomedical research models and to ensure New Jersey, and the country as a whole, become better places to conduct research.
Expertise in Automated Cell Counting and Analysis
In 2003, the founders of Nexcelom introduced the CP2, a convenient tool to assist with manual cell counting. According to Dr. Jean Qiu, founder and CTO at Nexcelom,
One day a customer at the NIH asked us to 'make counting under the microscope go away.' We invented Cellometer Auto T4 to measure cell concentration and viability.
Since then, Nexcelom has expanded the product range to accommodate researchers analyzing small cells, primary cells, and researchers looking to perform cell-based assays. With multiple patents pending, Nexcelom is a clear leader and innovator in the field of image-based cytometry for cell analysis.
Proven Performance
Thousands of customers, including the top ten pharmaceutical companies, have come to rely on Cellometer instruments for automated cell concentration & viability analysis.
The Cellometer has provided a much faster and more accurate method of counting the 100s of samples we need to set up for flow cytometry analysis." - Dr. Janice Pluth, Lawrence Berkeley Laboratory
From the large breweries performing yeast fermentation monitoring to specialized pharmaceutical labs analyzing fragile hepatocytes for toxicology studies, researchers in a wide range of industries have integrated Cellometer instruments into their laboratory testing.
Dedicated Applications Support
Nexcelom is focused on providing novel tools to meet the specific needs of today's researchers. Our applications specialists are in the field with customers every day, analyzing new cell types, validating new cell-based assays, and exploring new therapeutic areas.
Through joint application development, we learn from our customers, the experts in their fields, and assist with integration into their current workflows."- Dr. Bo Lin, Director of Applications Development
Our experienced technical support and applications specialists are committed to ensuring products work successfully in the customer's hands and are always eager to provide support via the phone, Internet, and on-site visits.
Simply put, that's our mission: providing innovative cannabis products to all customers. From our sweet-and-sour THC and CBD gummies to our line of affordable inhalers, each packed with pure THC liquid for particulate delivery, we work to help enthusiasts and cannabis patients relax, unwind, and Njoy life.
Nicoya is a Canadian biotechnology company specializing in innovative biosensor technology for label-free biomolecular characterization. In their mission to improve human life, they empower researchers with affordable and user-friendly solutions that maximize their access to high-quality data and advance their understanding of human diseases. With their world-class expertise in nanotechnology and microfluidics, Nicoya is now helping hundreds of scientists succeed in over 40 countries.
Visit https://nicoyalife.com/ to learn more.
NMI TT Pharmaservices is an established provider of non-clinical contract research for protein profiling services, custom cell services, and electrophysiology services. The company has a long-standing CRO track record with numerous small, medium and large pharma and biotech companies worldwide. The services are accessible through direct contracts or Master Service Agreements (MSAs), or immediately via online marketplaces Scientist.com and ScienceExchange.
The North American 3Rs Collaborative (NA3RsC) is a nonprofit organization whose mission is to advance science, innovation, and research animal welfare. We facilitate collaborative opportunities to refine, reduce, and replace animals in research. We are unique in growing partnerships between academics, pharmaceutical companies, vendors, technology providers, contract research organizations, government organizations, regulatory agents, and other non-profits. This diversity is reflected in our organizational leadership. Such partnerships are essential for the development and implementation of the 3Rs. We aim to be a leading authority on the 3Rs in North America & globally.
NuProbe takes a multi-platform approach to apply its breakthrough technologies in genomics research to enable diseases to be detected, treated, and cured at early stages for better outcomes with lower costs.
Founded in 2016 and building on scientific findings licensed from the Wyss Institute at Harvard and Rice University, NuProbe is a privately held company with facilities in the US (Houston, TX) and China (Shanghai). The company has assembled an executive team of industry veterans, world-renowned scientists, and entrepreneurs.